{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:47:03Z","timestamp":1743792423520,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":100,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071606346"},{"type":"electronic","value":"9781071606353"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0635-3_2","type":"book-chapter","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T11:02:38Z","timestamp":1590404558000},"page":"9-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Computer-Aided Drug Design for the Identification of Novel Antischistosomal Compounds"],"prefix":"10.1007","author":[{"given":"J\u00e9ssika","family":"de Oliveira Viana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus T.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"2_CR1","unstructured":"World Health Organization (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44440\/9789241564090_eng.pdf;jsessionid=FB90F2B5E9FB386995329EAE7523301B?sequence=1. Accessed 25 May 2019"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE et al (2014) Human schistosomiasis. Lancet 383:2253\u20132264","journal-title":"Lancet"},{"key":"2_CR3","unstructured":"World Health Organization (2019) Schistosomiasis. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/schistosomiasis. Accessed 20 May 2019"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1136\/bmj.d2651","volume":"342","author":"DJ Gray","year":"2011","unstructured":"Gray DJ, Ross AG, Li YS et al (2011) Diagnosis and management of schistosomiasis. BMJ 342:2651","journal-title":"BMJ"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"P Steinmann","year":"2006","unstructured":"Steinmann P, Keiser J, Bos R et al (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411\u2013425","journal-title":"Lancet Infect Dis"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/S0074-02762006000900012","volume":"101","author":"RSD Amaral","year":"2006","unstructured":"Amaral RSD, Tauil PL, Lima DD et al (2006) An analysis of the impact of the Schistosomiasis control programme in Brazil [in English]. Mem Inst Oswaldo Cruz 101:79\u201385","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/03008880802285032","volume":"42","author":"DM Parkin","year":"2008","unstructured":"Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 42:12\u201320","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.aids.0000210614.45212.0a","volume":"20","author":"EF Kjetland","year":"2006","unstructured":"Kjetland EF, Ndhlovu PD, Gomo E et al (2006) Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20:593\u2013600","journal-title":"AIDS"},{"issue":"1","key":"2_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1742395307084407","volume":"4","author":"CH King","year":"2008","unstructured":"King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4(1):65\u201379","journal-title":"Chronic Illn"},{"issue":"4","key":"2_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005517","volume":"11","author":"CH King","year":"2017","unstructured":"King CH (2017) The evolving schistosomiasis agenda 2007\u20132017. Why we are moving beyond morbidity control toward elimination of transmission. PLoS Negl Trop Dis 11(4):e0005517","journal-title":"PLoS Negl Trop Dis"},{"key":"2_CR11","unstructured":"World Health Organization (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42588\/WHO_TRS_912.pdf?sequence=1&isAllowed=y. Accessed 15 May 2019"},{"key":"2_CR12","first-page":"409","volume":"25","author":"CI Valencia","year":"1994","unstructured":"Valencia CI, Catto BA, Webster LT et al (1994) Concentration time course of praziquantel in Filipinos with mild Schistosoma japonicum infection. Southeast Asian J Trop Med Public Health 25:409\u2013414","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"5","key":"2_CR13","first-page":"335","volume":"6","author":"S Xiao","year":"1998","unstructured":"Xiao S, You J, Mei J et al (1998) In vitro and in vivo effect of levopraziquantel, dextropraziquantel versus racemic praziquantel on different developmental stages of Schistosoma japonicum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 6(5):335\u2013341","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jac\/dkt491","volume":"69","author":"P Olliaro","year":"2014","unstructured":"Olliaro P, Delgado-Romero P, Keiser J (2014) The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J Antimicrob Chemother 69:863\u2013870","journal-title":"J Antimicrob Chemother"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF03189504","volume":"3","author":"KU B\u00fchring","year":"1978","unstructured":"B\u00fchring KU, Diekmann HW, M\u00fcller H et al (1978) Metabolism of praziquantel in man. Eur J Drug Metab Pharmacokinet 3:179\u2013190","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2_CR16","first-page":"1132","volume":"34","author":"DHG Wegner","year":"1984","unstructured":"Wegner DHG (1984) The profile of the trematodicidal compound praziquantel. Arzneimittelforschung 34:1132\u20131136","journal-title":"Arzneimittelforschung"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-3156.2009.02234.x","volume":"14","author":"CL Black","year":"2009","unstructured":"Black CL, Steinauer ML, Mwinzi PN et al (2009) Impact of intense, longitudinal retreatment with praziquantel on cure rates of Schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. Tropical Med Int Health 14:450\u2013457","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"2_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1179\/000349803125002553","volume":"97","author":"EK N\u2019Goran","year":"2003","unstructured":"N\u2019Goran EK, Gnaka HN, Tanner M et al (2003) Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from cote d\u2019Ivoire. Ann Trop Med Parasitol 97(1):37\u201351","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"2_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1473-3099(10)70161-4","volume":"10","author":"CO Obonyo","year":"2010","unstructured":"Obonyo CO, Muok EM, Mwinzi PN (2010) Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomized controlled trial. Lancet Infect Dis 10(9):603\u2013611","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2221-1691(12)60049-5","volume":"2","author":"B Erko","year":"2012","unstructured":"Erko B, Degarege A, Tadesse K et al (2012) Efficacy and side effects of praziquantel treatment of Schistosomiasis mansoni in Shesha Kekele elementary school, Wondo genet, southern Ethiopia. Asian Pac J Trop Biomed 2(3):235\u2013239","journal-title":"Asian Pac J Trop Biomed"},{"issue":"11","key":"2_CR21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/tmi.12187","volume":"18","author":"B Reta","year":"2013","unstructured":"Reta B, Erko B (2013) Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete town, northeastern Ethiopia. Tropical Med Int Health 18(11):1338\u20131343","journal-title":"Tropical Med Int Health"},{"key":"2_CR22","unstructured":"World Health Organization (1998) International Strategies for Tropical Disease Treatment: Experiences with Praziquantel. Edited by Reich, MR. http:\/\/apps.who.int\/medicinedocs\/pdf\/whozip48e\/whozip48e.pdf. Accessed 15 May 2019"},{"issue":"6","key":"2_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001165","volume":"5","author":"PL Olliare","year":"2011","unstructured":"Olliare PL, Vaillant MT, Belizario VJ et al (2011) A multicentre randomized controlled trial of the efficacy and safety of single dose praziquantel at 40 mg\/kg vs 60 mg\/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl Trop Dis 5(6):e1165","journal-title":"PLoS Negl Trop Dis"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","volume":"68","author":"D Cioli","year":"1995","unstructured":"Cioli D, Pica-Mattoccia L, Archer S (1995) Antischistosomal drugs: past, present\u2026 and future? Pharmacol Ther 68:35\u201385","journal-title":"Pharmacol Ther"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","volume":"195","author":"D Cioli","year":"2014","unstructured":"Cioli D, Pica-Mattoccia L, Basso A et al (2014) Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 195:23\u201329","journal-title":"Mol Biochem Parasitol"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2147\/DDDT.S98096","volume":"10","author":"Q Sun","year":"2016","unstructured":"Sun Q, Mao R, Wang D et al (2016) The cytotoxicity study of praziquantel enantiomers. Drug Des Devel Ther 10:2061","journal-title":"Drug Des Devel Ther"},{"key":"2_CR27","unstructured":"Almeida AP, Mendes T, Ferreira P et al (2018) Comparative proteomics reveals characteristic proteins on praziquantel-resistance in Schistosoma mansoni. BioRxiv, 314724"},{"key":"2_CR28","unstructured":"World Health Organization (2006) Preventive chemotherapy in human helminthiasis. Coordinated use of antihelminthic drugs in control interventions: a manual for health professionals and programme managers. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/43545\/9241547103_eng.pdf?sequence=1. Accessed 14 May 2019"},{"key":"2_CR29","unstructured":"World Health Organization (2013) Sustaining the drive to overcome the global impact of neglected tropical diseases. Second WHO report on neglected tropical diseases. http:\/\/apps.who.int\/iris\/bitstream\/10665\/80245\/1\/WHO_HTM_NTD_2013.2_eng.pdf. Accessed 14 May 2019"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00436-002-0751-z","volume":"90","author":"D Cioli","year":"2003","unstructured":"Cioli D, Pica-Mattoccia L (2003) Praziquantel. Parasitol Res 90:3\u20139","journal-title":"Parasitol Res"},{"issue":"3","key":"2_CR31","first-page":"190","volume":"81","author":"ML Ferrari","year":"2003","unstructured":"Ferrari ML, Coelho PM, Antunes CM et al (2003) Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ 81(3):190\u2013196","journal-title":"Bull World Health Organ"},{"issue":"9212","key":"2_CR32","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/S0140-6736(00)02114-0","volume":"355","author":"J Utzinger","year":"2000","unstructured":"Utzinger J, N'Goran EK, N'Dri A et al (2000) Oral artemether for prevention of Schistosoma mansoni infection: randomized controlled trial. Lancet 355(9212):1320\u20131325","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/S0074-02761991000600042","volume":"86","author":"N Araujo","year":"1991","unstructured":"Araujo N, Kohn A, Katz N (1991) Activity of the artemether in experimental Schisosomiasis mansoni. Mem Inst Oswaldo Cruz 86(Suppl 2):185\u2013188","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"10","key":"2_CR34","doi-asserted-by":"publisher","first-page":"e6732","DOI":"10.1371\/journal.pone.0006732","volume":"4","author":"MS Issoko","year":"2009","unstructured":"Issoko MS, Dabo A, Traore H et al (2009) Efficacy of artesunate + sulfamethoxypyrazine\/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One 4(10):e6732","journal-title":"PLoS One"},{"issue":"10","key":"2_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2471\/BLT.08.053041","volume":"86","author":"XY Hou","year":"2008","unstructured":"Hou XY, McManus DP, Gray DJ et al (2008) A randomized double-blind placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute Schistosomiasis japonica in China. Bull World Health Organ 86(10):788\u2013795","journal-title":"Bull World Health Organ"},{"issue":"9","key":"2_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1473-3099(10)70169-9","volume":"10","author":"J Utzinger","year":"2010","unstructured":"Utzinger J, Tanner M, Keiser J (2010) ACTs for schistosomiasis: do they act? Lancet Infect Dis 10(9):579\u2013581","journal-title":"Lancet Infect Dis"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1136\/bmj.d2651","volume":"342","author":"DJ Gray","year":"2011","unstructured":"Gray DJ, Ross AG, Li YS (2011) Diagnosis and management of schistosomiasis. BMJ 342:2651","journal-title":"BMJ"},{"issue":"1","key":"2_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00415-011-6133-7","volume":"259","author":"AG Ross","year":"2012","unstructured":"Ross AG, McManus DP, Farrar J et al (2012) Neuroschistosomiasis. J Neurol 259(1):22\u201332","journal-title":"J Neurol"},{"issue":"1","key":"2_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4269\/ajtmh.1999.61.47","volume":"61","author":"R Fowler","year":"1999","unstructured":"Fowler R, Lee C, Keystone JS et al (1999) The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg 61(1):47\u201350","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"2_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1590\/S0037-86822008000600029","volume":"41","author":"JR Lambertucci","year":"2008","unstructured":"Lambertucci JR, Voieta I, Silveira IS (2008) Cerebral schistosomiasis mansoni. Rev Soc Bras Med Trop 41(6):693\u2013694","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"2_CR41","first-page":"21","volume":"89","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Schistosomiasis: number of people treated in 2014. Wkly Epidemiol Rec 89(4):21\u201328. https:\/\/www.who.int\/wer\/2016\/wer9105.pdf?ua=1. Accessed 15 May 2019","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"2_CR42","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.yexcr.2010.02.041","volume":"316","author":"J Weigelt","year":"2010","unstructured":"Weigelt J (2010) Structural genomics \u2013 impact on biomedicine and drug discovery. Exp Cell Res 316(8):1332\u20131338","journal-title":"Exp Cell Res"},{"issue":"4","key":"2_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5808\/GI.2013.11.4.289","volume":"11","author":"S Kumar","year":"2013","unstructured":"Kumar S, Jena L, Daf S et al (2013) hpvPDB: an online proteome reserve for human papillomavirus. Genomics Inform 11(4):289\u2013291","journal-title":"Genomics Inform"},{"issue":"1","key":"2_CR44","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(1):1100\u20131107","journal-title":"Nucleic Acids Res"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/nar\/gks1195","volume":"41","author":"DA Benson","year":"2013","unstructured":"Benson DA, Cavanaugh M, Clark K et al (2013) GenBank. Nucleic Acids Res 41:36\u201342","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2_CR46","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4155\/fmc.11.18","volume":"3","author":"GL Wilson","year":"2011","unstructured":"Wilson GL, Lill MA (2011) Integrating structure-based and ligand-based approaches for computational drug design. Future Med Chem 3(6):735\u2013750","journal-title":"Future Med Chem"},{"issue":"1","key":"2_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10822-011-9518-x","volume":"26","author":"J Blaney","year":"2012","unstructured":"Blaney J (2012) A very short history of structure-based design: how did we get here and where do we need to go? J Comput Aided Mol Des 26(1):13\u201314","journal-title":"J Comput Aided Mol Des"},{"issue":"16","key":"2_CR48","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E Lionta","year":"2014","unstructured":"Lionta E, Spyrou G, Vassilatis DK et al (2014) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 14(16):1923\u20131938","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"2_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/ci5000196","volume":"54","author":"KR Valasani","year":"2014","unstructured":"Valasani KR, Vangavaragu JR, Day VW et al (2014) Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors. J Chem Inf Model 54(3):902\u2013912","journal-title":"J Chem Inf Model"},{"issue":"1","key":"2_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/jm900817u","volume":"53","author":"AR Leach","year":"2010","unstructured":"Leach AR, Gillet VJ, Lewis RA et al (2010) Three-dimensional pharmacophore methods in drug discovery. J Med Chem 53(2):539\u2013558","journal-title":"J Med Chem"},{"issue":"14","key":"2_CR52","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1016\/j.bmcl.2014.05.004","volume":"24","author":"A Mittal","year":"2014","unstructured":"Mittal A, Paliwal S, Sharma M et al (2014) Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity. Bioorg Med Chem Lett 24(14):3137\u20133141","journal-title":"Bioorg Med Chem Lett"},{"issue":"17","key":"2_CR53","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2174\/092986711795933731","volume":"18","author":"T Mavromoustakos","year":"2011","unstructured":"Mavromoustakos T, Durdagi S, Koukoulitsa C et al (2011) Strategies in the rational drug design. Curr Med Chem 18(17):2517\u20132530","journal-title":"Curr Med Chem"},{"issue":"7","key":"2_CR54","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM et al (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52(7):1757\u20131768","journal-title":"J Chem Inf Model"},{"issue":"Suppl. 2","key":"2_CR55","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/nar\/gkp456","volume":"37","author":"Y Wang","year":"2009","unstructured":"Wang Y, Xiao J, Suzek TO (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 37(Suppl. 2):623\u2013633","journal-title":"Nucleic Acids Res"},{"issue":"7253","key":"2_CR56","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature08160","volume":"460","author":"M Berriman","year":"2009","unstructured":"Berriman M, Haas BJ, LoVerde PT et al (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460(7253):352","journal-title":"Nature"},{"issue":"5","key":"2_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijpara.2006.12.012","volume":"37","author":"PJ Brindley","year":"2007","unstructured":"Brindley PJ, Pearce EJ (2007) Genetic manipulation of schistosomes. Int J Parasitol 37(5):465\u2013473","journal-title":"Int J Parasitol"},{"issue":"2","key":"2_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng.1065","volume":"44","author":"ND Young","year":"2012","unstructured":"Young ND, Jex AR, Li B et al (2012) Whole-genome sequence of Schistosoma haematobium. Nat Genet 44(2):221","journal-title":"Nat Genet"},{"issue":"suppl 1","key":"2_CR59","first-page":"579","volume":"37","author":"A Zerlotini","year":"2008","unstructured":"Zerlotini A, Heiges M, Wang H et al (2008) SchistoDB: a Schistosoma mansoni genome resource. Nucleic Acids Res 37(suppl 1):579\u2013582","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087594","volume":"9","author":"L Rojo-Arreola","year":"2014","unstructured":"Rojo-Arreola L, Long T, Asarnow D et al (2014) Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis. PLoS One 9(1):e87594","journal-title":"PLoS One"},{"key":"2_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003645","volume":"9","author":"M Marek","year":"2013","unstructured":"Marek M, Kannan S, Hauser AT et al (2013) Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni. PLoS Pathog 9:e1003645","journal-title":"PLoS Pathog"},{"issue":"2","key":"2_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031456","volume":"7","author":"L Song","year":"2012","unstructured":"Song L, Li J, Xie S et al (2012) Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum. PLoS One 7(2):e31456","journal-title":"PLoS One"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jmgm.2008.10.009","volume":"27","author":"M Sharma","year":"2010","unstructured":"Sharma M, Khanna S, Bulusu G et al (2010) Corrigendum to comparative modeling of thioredoxin glutathione reductase from Schistosoma mansoni: a multifunctional target for antischistosomal drug discovery. J Mol Graph Model 27:665\u2013675","journal-title":"J Mol Graph Model"},{"issue":"3","key":"2_CR64","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/prot.21986","volume":"72","author":"F Angelucci","year":"2008","unstructured":"Angelucci F, Miele AE, Boumis G et al (2008) Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase. Proteins 72(3):936\u2013945","journal-title":"Proteins"},{"issue":"6","key":"2_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040206","volume":"4","author":"AN Kuntz","year":"2007","unstructured":"Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL et al (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med 4(6):e206","journal-title":"PLoS Med"},{"issue":"4","key":"2_CR66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nm1737","volume":"14","author":"AA Sayed","year":"2008","unstructured":"Sayed AA, Simeonov A, Thomas CJ et al (2008) Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat Med 14(4):407","journal-title":"Nat Med"},{"issue":"1","key":"2_CR67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40249-015-0071-z","volume":"4","author":"T Li","year":"2015","unstructured":"Li T, Ziniel PD, He PQ et al (2015) High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis. Infect Dis Poverty 4(1):40","journal-title":"Infect Dis Poverty"},{"issue":"42","key":"2_CR68","doi-asserted-by":"publisher","first-page":"28977","DOI":"10.1074\/jbc.M109.020701","volume":"284","author":"F Angelucci","year":"2009","unstructured":"Angelucci F, Sayed AA, Williams DL (2009) Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin structural and kinetic aspects. J Biol Chem 284(42):28977\u201328985","journal-title":"J Biol Chem"},{"issue":"3","key":"2_CR69","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381\u2013395","journal-title":"Cell Res"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.bbrc.2008.10.090","volume":"377","author":"F Oger","year":"2008","unstructured":"Oger F, Dubois F, Caby S et al (2008) The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni. Biochem Biophys Res Commun 377:1079\u20131084","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molbiopara.2009.06.001","volume":"168","author":"F Dubois","year":"2009","unstructured":"Dubois F, Caby S, Oger F et al (2009) Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. Mol Biochem Parasitol 168:7\u201315","journal-title":"Mol Biochem Parasitol"},{"issue":"45","key":"2_CR72","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.2174\/1381612823666171011100532","volume":"23","author":"VHB Serr\u00e3o","year":"2017","unstructured":"Serr\u00e3o VHB, Pereira HD, de Souza JRT et al (2017) Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Curr Pharm Des 23(45):6967\u20136983","journal-title":"Curr Pharm Des"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molbiopara.2017.04.004","volume":"214","author":"AE Zeraik","year":"2017","unstructured":"Zeraik AE, Serr\u00e3o VHB, Romanello L et al (2017) Schistosoma mansoni displays an adenine phosphoribosyltransferase preferentially expressed in mature female gonads and vitelaria. Mol Biochem Parasitol 214:82\u201386","journal-title":"Mol Biochem Parasitol"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cbpb.2017.07.001","volume":"213","author":"MH El Kouni","year":"2017","unstructured":"El Kouni MH (2017) Pyrimidine metabolism in schistosomes: a comparison with other parasites and the search for potential chemotherapeutic targets. Comp Biochem Physiol B Biochem Mol Biol 213:55\u201380","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.actatropica.2017.03.007","volume":"170","author":"VH Serr\u00e3o","year":"2017","unstructured":"Serr\u00e3o VH, Romanello L, Cassago A et al (2017) Structure and kinetics assays of recombinant Schistosoma mansoni dihydrofolate reductase. Acta Trop 170:190\u2013196","journal-title":"Acta Trop"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.abb.2017.06.019","volume":"632","author":"RA Reis","year":"2017","unstructured":"Reis RA, Calil FA, Feliciano PR et al (2017) The dihydroorotate dehydrogenases: past and present. Arch Biochem Biophys 632:175\u2013191","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"2_CR77","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1006\/prep.1998.0925","volume":"13","author":"B Bader","year":"1998","unstructured":"Bader B, Knecht W, Fries M et al (1998) Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase. Protein Expr Purif 13(3):414\u2013422","journal-title":"Protein Expr Purif"},{"issue":"2","key":"2_CR78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molbiopara.2012.04.009","volume":"184","author":"MT Hortua","year":"2012","unstructured":"Hortua MT, Huynh MH, Garavito MF et al (2012) Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from toxoplasma gondii. Mol Biochem Parasitol 184(2):71\u201381","journal-title":"Mol Biochem Parasitol"},{"issue":"12","key":"2_CR79","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2174\/138955711797247707","volume":"11","author":"VK Vyas","year":"2011","unstructured":"Vyas VK, Ghate M (2011) Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors. Mini Rev Med Chem 11(12):1039\u20131055","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"2_CR80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jgg.2015.04.001","volume":"42","author":"M Loeffler","year":"2015","unstructured":"Loeffler M, Carrey EA, Zameitat E (2015) Orotic acid, more than just an intermediate of pyrimidine de novo synthesis. J Genet Genomics 42(5):207\u2013219","journal-title":"J Genet Genomics"},{"issue":"2","key":"2_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molbiopara.2012.08.003","volume":"185","author":"AA Religa","year":"2012","unstructured":"Religa AA, Waters AP (2012) Sirtuins of parasitic protozoa: in search of function (s). Mol Biochem Parasitol 185(2):71\u201388","journal-title":"Mol Biochem Parasitol"},{"issue":"1\u20132","key":"2_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-1119(02)00842-9","volume":"296","author":"B Vergnes","year":"2002","unstructured":"Vergnes B, Sereno D, Madjidian-Sereno N et al (2002) Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death. Gene 296(1\u20132):139\u2013150","journal-title":"Gene"},{"issue":"6","key":"2_CR83","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/onc.2008.436","volume":"28","author":"E Lara","year":"2009","unstructured":"Lara E, Mai A, Calvanese V et al (2009) Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 28(6):781","journal-title":"Oncogene"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biochi.2019.01.006","volume":"158","author":"MC Nonato","year":"2019","unstructured":"Nonato MC, de P\u00e1dua RA, David JS, RAG R et al (2019) Structural basis for the design of selective inhibitors for Schistosoma mansoni dihydroorotate dehydrogenase. Biochimie 158:180\u2013190","journal-title":"Biochimie"},{"issue":"1","key":"2_CR85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0166-6851(94)90091-4","volume":"67","author":"AM Smith","year":"1994","unstructured":"Smith AM, Dalton JP, Clough KA et al (1994) Adult Schistosoma mansoni express cathepsin L proteinase activity. Mol Biochem Parasitol 67(1):11\u201319","journal-title":"Mol Biochem Parasitol"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/IAI.67.1.368-374.1999","volume":"67","author":"CP Brady","year":"1999","unstructured":"Brady CP, Dowd AJ, Brindley PJ et al (1999) Recombinant expression and localization of Schistosoma mansoni cathepsin L1 support its role in the degradation of host haemoglobin. Infect Immun 67:368\u2013374","journal-title":"Infect Immun"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0169-4758(95)80045-X","volume":"11","author":"JP Dalton","year":"1995","unstructured":"Dalton JP, Smith AM, Clough KA et al (1995) Digestion of haemoglobin by schistosomes: 35 years on. Parasitol Today 11:299\u2013303","journal-title":"Parasitol Today"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1128\/iai.64.4.1328-1334.1996","volume":"64","author":"JP Dalton","year":"1996","unstructured":"Dalton JP, Clough KA, Jones MK et al (1996) Characterization of the cathepsin-like cysteine proteinases of Schistosoma mansoni. Infect Immun 64:1328\u20131334","journal-title":"Infect Immun"},{"key":"2_CR89","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0169-4758(88)90002-6","volume":"4","author":"JH McKerrow","year":"1988","unstructured":"McKerrow JH, Doenhoff MJ (1988) Schistosome proteases. Parasitol Today 4:334\u2013340","journal-title":"Parasitol Today"},{"issue":"2","key":"2_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1359-6446(99)01451-8","volume":"5","author":"DE Clark","year":"2000","unstructured":"Clark DE, Picket SD (2000) Computational methods for the prediction of \u2018drug-likeness\u2019. Drug Discov Today 5(2):49\u201358","journal-title":"Drug Discov Today"},{"issue":"8","key":"2_CR91","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd.2016.29","volume":"15","author":"DE Scott","year":"2016","unstructured":"Scott DE, Bayly AR, Abell C et al (2016) Small molecules, big targets: drug discovery faces the protein\u2013protein interaction challenge. Nat Rev Drug Discov 15(8):533","journal-title":"Nat Rev Drug Discov"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"957107","DOI":"10.1155\/2014\/957107","volume":"2014","author":"S Gaba","year":"2014","unstructured":"Gaba S, Jamal S, Scaria V, Drug Discovery Consortium (2014) Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase. Sci World J 2014:957107","journal-title":"Sci World J"},{"issue":"10","key":"2_CR93","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1021\/ci5004653","volume":"54","author":"S Kannan","year":"2014","unstructured":"Kannan S, Melesina J, Hauser AT et al (2014) Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation. J Chem Inf Model 54(10):3005\u20133019","journal-title":"J Chem Inf Model"},{"issue":"7","key":"2_CR94","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1021\/acs.jcim.6b00055","volume":"56","author":"CC Melo-Filho","year":"2016","unstructured":"Melo-Filho CC, Dantas RF, Braga RC et al (2016) QSAR-driven discovery of novel chemical scaffolds active against Schistosoma mansoni. J Chem Inf Model 56(7):1357\u20131372","journal-title":"J Chem Inf Model"},{"key":"2_CR95","doi-asserted-by":"publisher","first-page":"651","DOI":"10.12688\/f1000research.18904.1","volume":"8","author":"B Otarigho","year":"2019","unstructured":"Otarigho B (2019) Structural, functional and docking analysis against Schistosoma mansoni dihydroorotate dehydrogenase for potential chemotherapeutic drugs. F1000 Res 8:651","journal-title":"F1000 Res"},{"issue":"3","key":"2_CR96","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/molecules23030566","volume":"23","author":"C Simoben","year":"2018","unstructured":"Simoben C, Robaa D, Chakrabarti A et al (2018) A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing. Molecules 23(3):566","journal-title":"Molecules"},{"issue":"3","key":"2_CR97","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11033-014-3816-z","volume":"42","author":"R Singh","year":"2015","unstructured":"Singh R, Pandey PN (2015) Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis. Mol Biol Rep 42(3):689\u2013698","journal-title":"Mol Biol Rep"},{"issue":"5","key":"2_CR98","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1080\/07391102.2015.1065205","volume":"34","author":"R Singh","year":"2016","unstructured":"Singh R, Singh S, Pandey PN (2016) In-silico analysis of sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors. J Biomol Struct Dyn 34(5):1042\u20131051","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"2_CR99","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s40064-016-1891-4","volume":"5","author":"R Singh","year":"2016","unstructured":"Singh R, Yadav BS, Singh S et al (2016) In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates. Springerplus 5(1):286","journal-title":"Springerplus"},{"issue":"5","key":"2_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123996","volume":"10","author":"A Zafar","year":"2015","unstructured":"Zafar A, Ahmad S, Rizvi A et al (2015) Novel non-peptide inhibitors against SmCL1 of Schistosoma mansoni: in silico elucidation, implications and evaluation via knowledge-based drug discovery. PLoS One 10(5):e0123996","journal-title":"PLoS One"}],"container-title":["Methods in Molecular Biology","Schistosoma mansoni"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0635-3_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T05:18:49Z","timestamp":1649827129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-0635-3_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071606346","9781071606353"],"references-count":100,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0635-3_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"26 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}